共 9 条
[1]
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. Atkins G,Haynes DR,Graves SE,et al. Journal of Bone and Mineral Research . 2000
[2]
Effect of the high-affinity estrogen receptor ligand ICI182780 on the rat tibia. Sibonga JD,Dobnig H,Harden RM,et al. The Journal of Endocrinology . 1998
[3]
Transforming growth factorbeta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclastlike cells. Murakami T,Yamamoto M,Ono K,et al. Biochemical and Biophysical Research Communications . 1998
[4]
Molecularcloninglaboratorymanual. SumbrookJ. . 1989
[5]
Skeletal effects of estrogen. Turner RT,Riggs BL,Spelsberg TC. Endocrine Reviews . 1994
[6]
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. Emery J G,Mcdonnell P,Burke M B,et al. Journal of Biological Chemistry . 1998
[7]
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Takahashi N,Udagawa N,Suda T. Biochemical and Biophysical Research Communications . 1999
[8]
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Hofbauer L C,Khosla S,Dunstan C R,et al. The Journal of Endocrinology . 1999
[9]
Osteoprotegerin:anovel secreted protein involved in the regulation of bone density. Simonet WS,Lacey DL,Dunstan CR,et al. Cell . 1997